-
公开(公告)号：US20210240771A1
公开(公告)日：2021-08-05
申请号：US16777773
申请日：2020-01-30
Applicant: Rahul Kumar Namdev , Pawan Kumar Gupta
Inventor： Rahul Kumar Namdev , Pawan Kumar Gupta
IPC: G06F16/9035 , G06N20/10 , G06F21/33
Abstract: A single-click matchmaking system and method is disclosed providing streamlined, fast, interactive and intelligent search processes for matchmaking. The single-click matchmaking for recommending at least one match comprises receiving a profile of the user based on an input given by the user at an application running on the computing device, predicting a plurality of self-attributes of the user based on the profile of the user, predicting a plurality of preferred attributes based on the plurality of self-attributes of the user, accessing a memory configured to store data corresponding to a plurality of entities, determining the match from the plurality of entities and recommending the at least one match to display at the computing device of the user.
-
公开(公告)号：US11409807B2
公开(公告)日：2022-08-09
申请号：US16777773
申请日：2020-01-30
Applicant: Rahul Kumar Namdev , Pawan Kumar Gupta
Inventor： Rahul Kumar Namdev , Pawan Kumar Gupta
IPC: G06F16/00 , G06F16/9035 , G06F21/33 , G06N20/10
Abstract: A single-click matchmaking system and method is disclosed providing streamlined, fast, interactive and intelligent search processes for matchmaking. The single-click matchmaking for recommending at least one match comprises receiving a profile of the user based on an input given by the user at an application running on the computing device, predicting a plurality of self-attributes of the user based on the profile of the user, predicting a plurality of preferred attributes based on the plurality of self-attributes of the user, accessing a memory configured to store data corresponding to a plurality of entities, determining the match from the plurality of entities and recommending the at least one match to display at the computing device of the user.
-
Patent Agency Ranking
3.发明授权Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions 有权用于纳米颗粒药物组合物的生物相容性，非生物降解性，无毒性聚合物公开(公告)号：US08338562B2
公开(公告)日：2012-12-25
申请号：US12159310
申请日：2006-12-26
Applicant: Anand C. Burman , Rama Mukherjee , Dhiraj Khattar , Sanjoy Mullick , Manu Jaggi , Manoj Kumar Singh , Mukesh Kumar , Deepak Prusthy , Pawan Kumar Gupta , Rajendran Praveen , Shobhit Singh
Inventor： Anand C. Burman , Rama Mukherjee , Dhiraj Khattar , Sanjoy Mullick , Manu Jaggi , Manoj Kumar Singh , Mukesh Kumar , Deepak Prusthy , Pawan Kumar Gupta , Rajendran Praveen , Shobhit Singh
IPC: C08F26/00
CPC classification number: A61K47/32 , C08F220/56 , C08F222/12 , C08F222/385 , C08F226/10
Abstract: The invention relates to a biocompatible, non-biodegradable, and non-toxic polymer of formula (I), comprising of three monomeric units, selected from 1-Vinylpyrrolidone (VP), N-Isopropylacrylamide (NIPAM), and ester of Maleic anhydride and Polyethylene glycol (MPEG), cross-linked with a bi-functional vinyl derivative, of high purity and substantially free of respective toxic monomeric contaminants, and a process for preparation thereof. The invention further relates to nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds comprising the polymer of the invention, which are safe, less-toxic and convenient for bedside administration to patients in need thereof. Furthermore, the invention relates to a highly selective method for preparation of nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds.
Abstract translation: 本发明涉及式（I）的生物相容性，不可生物降解的和无毒的聚合物，其包含三种单体单元，其选自1-乙烯基吡咯烷酮（VP），N-异丙基丙烯酰胺（NIPAM）和马来酸酐的酯和 与双官能乙烯基衍生物交联的聚乙二醇（MPEG），其纯度高，基本上不含有毒的单体污染物及其制备方法。 本发明还涉及难溶于水的药物或包含本发明聚合物的化合物的纳米颗粒药物组合物，其对于有需要的患者的床边给药是安全的，毒性较小且方便的。 此外，本发明涉及用于制备难溶于水的药物或化合物的纳米颗粒药物组合物的高选择性方法。
-
4.发明申请A BIOCOMPATIBLE, NON-BIODEGRADABLE, NON-TOXIC POLYMER USEFUL FOR NANOPARTICLE PHARMACEUTICAL COMPOSITIONS 有权一种可生物降解，非生物降解的非毒性聚合物，用于纳米脂肪药物组合物公开(公告)号：US20090318661A1
公开(公告)日：2009-12-24
申请号：US12159310
申请日：2006-12-26
Applicant: Anand C. Burman , Rama Mukherjee , Dhiraj Khattar , Sanjoy Mullick , Manu Jaggi , Manoj Kumar Singh , Mukesh Kumar , Deepak Prusthy , Pawan Kumar Gupta , Rajendran Praveen , Shobhit Singh
Inventor： Anand C. Burman , Rama Mukherjee , Dhiraj Khattar , Sanjoy Mullick , Manu Jaggi , Manoj Kumar Singh , Mukesh Kumar , Deepak Prusthy , Pawan Kumar Gupta , Rajendran Praveen , Shobhit Singh
IPC: C08G61/04
CPC classification number: A61K47/32 , C08F220/56 , C08F222/12 , C08F222/385 , C08F226/10
Abstract: The invention relates to a biocompatible, non-biodegradable, and non-toxic polymer of formula (I), comprising of three monomeric units, selected from 1-Vinylpyrrolidone (VP), N-Isopropylacrylamide (NIPAM), and ester of Maleic anhydride and Polyethylene glycol (MPEG), cross-linked with a bi-functional vinyl derivative, of high purity and substantially free of respective toxic monomeric contaminants, and a process for preparation thereof. The invention further relates to nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds comprising the polymer of the invention, which are safe, less-toxic and convenient for bedside administration to patients in need thereof. Furthermore, the invention relates to a highly selective method for preparation of nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds.
Abstract translation: 本发明涉及式（I）的生物相容性，不可生物降解的和无毒的聚合物，其包含三种单体单元，其选自1-乙烯基吡咯烷酮（VP），N-异丙基丙烯酰胺（NIPAM）和马来酸酐的酯和 与双官能乙烯基衍生物交联的聚乙二醇（MPEG），其纯度高，基本上不含有毒的单体污染物及其制备方法。 本发明还涉及难溶于水的药物或包含本发明聚合物的化合物的纳米颗粒药物组合物，其对于有需要的患者的床边给药是安全的，毒性较小且方便的。 此外，本发明涉及用于制备难溶于水的药物或化合物的纳米颗粒药物组合物的高选择性方法。
-
5.发明授权公开(公告)号：US08956862B2
公开(公告)日：2015-02-17
申请号：US13062189
申请日：2010-11-25
Applicant: Rakhi Pal , Pawan Kumar Gupta , Prasanna Kumar Kemburu , Jyothi Prasanna , Satish Totey , Raviraja Neelavar Seetharam , Umesh Baikunje Golithadka , Anish Sen Majumdar
Inventor： Rakhi Pal , Pawan Kumar Gupta , Prasanna Kumar Kemburu , Jyothi Prasanna , Satish Totey , Raviraja Neelavar Seetharam , Umesh Baikunje Golithadka , Anish Sen Majumdar
IPC: C12N5/077 , C12N5/0775
CPC classification number: C12N5/0668 , C12N5/0663
Abstract: The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. Present invention also discloses the method of establishing Master Cell bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational Product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.
Abstract translation: 本发明公开了临床应用的间充质干细胞（MSC）的分离，汇集和进一步培养的方法。 本发明还公开了建立主细胞库的方法，随后是工作细胞库，其中将由称为骨髓衍生的MSC组成的被称为“同种异体骨髓衍生的MSC”的称为“调查产品/研究药用产品”的最终治疗组合物被配制用于临床应用。
-
6.发明申请BIOCOMPATIBLE, NON-BIODEGRADABLE, NON-TOXIC POLYMER USEFUL FOR NANOPARTICLE PHARMACEUTICAL COMPOSITIONS 有权生物易燃，非生物降解，非毒性聚合物用于纳米脂肪药物组合物公开(公告)号：US20130274211A1
公开(公告)日：2013-10-17
申请号：US13633638
申请日：2012-10-02
Applicant: Anand C. Burman , Rama Mukherjee , Dhiraj Khattar , Sanjoy Mullick , Manu Jaggi , Manoj Kumar Singh , Mukesh Kumar , Deepak Prusthy , Pawan Kumar Gupta , Rajendran Praveen , Shobhit Singh
Inventor： Anand C. Burman , Rama Mukherjee , Dhiraj Khattar , Sanjoy Mullick , Manu Jaggi , Manoj Kumar Singh , Mukesh Kumar , Deepak Prusthy , Pawan Kumar Gupta , Rajendran Praveen , Shobhit Singh
IPC: A61K47/32
CPC classification number: A61K47/32 , C08F220/56 , C08F222/12 , C08F222/385 , C08F226/10
Abstract: The invention relates to a biocompatible, non-biodegradable, and non-toxic polymer of formula (I), comprising of three monomeric units, selected from 1-Vinylpyrrolidne (VP), N-Isopropylactylamide (NIPAM), and ester of Maleic anhydride and Polyethylene glycol (MPEG), cross-linked with a bi-functional vinyl derivative, of high purity and substantially free of respective toxic monomeric contaminants, and a process for preparation thereof. The invention further relates to nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds comprising the polymer of the invention, which are safe, less-toxic and convenient for bedside administration to patients in need thereof. Furthermore, the invention relates to a highly selective method for preparation of nanoparticulate pharmaceutical compositions of poorly water-soluble drugs or compounds.
Abstract translation: 本发明涉及式（I）的生物相容性，不可生物降解的和无毒的聚合物，其包含三种单体单元，其选自1-乙烯基吡咯烷酮（VP），N-异丙基丙烯酰胺（NIPAM）和马来酸酐的酯和 与双官能乙烯基衍生物交联的聚乙二醇（MPEG），其纯度高，基本上不含有毒的单体污染物及其制备方法。 本发明还涉及难溶于水的药物或包含本发明聚合物的化合物的纳米颗粒药物组合物，其对于有需要的患者的床边给药是安全的，毒性较小且方便的。 此外，本发明涉及用于制备难溶于水的药物或化合物的纳米颗粒药物组合物的高选择性方法。
-
7.发明申请公开(公告)号：US20110229965A1
公开(公告)日：2011-09-22
申请号：US13062189
申请日：2010-11-25
Applicant: Rakhi Pal , Pawan Kumar Gupta , Prasanna Kumar Kemburu , Joyothi Prasanna , Satish Totey , Raviraja Neelavar Seetharam , Umesh Baikunje Golithadka , Anish Sen Majumdar
Inventor： Rakhi Pal , Pawan Kumar Gupta , Prasanna Kumar Kemburu , Joyothi Prasanna , Satish Totey , Raviraja Neelavar Seetharam , Umesh Baikunje Golithadka , Anish Sen Majumdar
IPC: C12N5/0775
CPC classification number: C12N5/0668 , C12N5/0663
Abstract: The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. Present invention also discloses the method of establishing Master Cell bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational Product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.
Abstract translation: 本发明公开了临床应用的间充质干细胞（MSC）的分离，汇集和进一步培养的方法。 本发明还公开了建立主细胞库的方法，随后是工作细胞库，其中将由称为骨髓衍生的MSC组成的被称为“同种异体骨髓衍生的MSC”的称为“调查产品/研究药用产品”的最终治疗组合物被配制用于临床应用。
-
-
-
-
-
-
Search Results
7
records
(took 0.018 seconds)
